The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Despite a 10% revenue decline, Standard BioTools Inc (LAB) showcases resilience with improved cost management and a strong ...

Discover Standard BioTools' Q1 2025 earnings insights: strategic proteomics growth, Illumina partnership potential, revenue guidance, and ...